When diagnosed with a disease, it’s often overwhelming to sort through mountains of medical data to figure out what therapies are available, pinpoint where they’re offered and identify the best experts to help. Complexity specialist Gunjan Bhardwaj recognizes that mining this information may best be done using a system of artificial intelligence and blockchain to help people, within and outside the medical field, navigate and comprehend such “deep, dense and diverse” data — entering a new era where all research is searchable and shareable.
Gunjan Bhardwaj studied at IIT Bombay, FH Pforzheim, MIT Sloan and EBS Oestrich-Winkel. He founded Innoplexus in 2011, a technology and product development company focused on solving challenges in life sciences and pharmaceuticals using artificial intelligence. Previously, he worked for BCG and EY. He has authored numerous articles for the Harvard Business Review, the MIT Sloan Review and other journals, and has advised businesses and nonprofit organizations. He lectures at the Frankfurt School of Finance and other schools.
Innoplexus, a leading AI and Life Sciences company, raises double-digit million dollar series C round from FinLab EOS VC and others
Frankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine learning and blockchain technologies, has received series C funding in the sum of double-digit millions. The round was co-led by FinLab EOS VC Fund, a venture capital fund backed by both Block.one, the publisher of the blockchain protocol EOSIO, and FinLab AG, one of Europe’s largest company builders and investors focused on financial services technologies. The FinLab EOS VC Fund invests across sectors and focuses on projects delivering value through the application of the EOSIO blockchain technology. Innoplexus AG represents FinLab EOS VC Fund’s largest investment to date.
Co-lead investor was existing shareholder ATAI Life Sciences, a global biotech company builder focused on developing breakthrough innovations in mental health. Innoplexus and ATAI closely cooperate to make the drug development process in mental health more effective and efficient by utilizing Innoplexus’ technology.
Innoplexus will use the funding to continue developing its AI and blockchain solutions and for international commercial expansion. “We are pleased to have gained yet another strong investor with the FinLab EOS VC Fund, who will support us to scale even further with their know-how and network,” says Dr. Gunjan Bhardwaj, Founder and CEO of Innoplexus.
Innoplexus’ products & solutions are used by global pharmaceutical and biotechnology companies as well as Clinical Research Organizations generating actionable insights across the drug development life cycle. The company is ushering in a new paradigm in drug discovery and development with its domain specific AI. Innoplexus is working with cutting edge technologies related to information retrieval, network analysis, computer vision, entity normalization and ontologies and has a strong focus on creating proprietary intellectual property.
“We fully believe in the mission of Innoplexus and will support them in transforming drug discovery and development into the areas of AI and blockchain. By integrating the EOSIO protocol, meaningful unpublished data could also be used for research. Innoplexus is leveraging the EOSIO blockchain to integrate unpublished data, as well as information that is trapped in silos, to aggregate growing data oceans and to accelerate drug discovery and development,’’ shares Juan Rodriguez, Managing Director of FinLab EOS VC Fund.
Image Credit: Innoplexus
News This Week
Lipid nanoparticles carry gene-editing cancer drugs past tumor defenses
As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break [...]
Graphene Nanosensor Detects Biomarkers Through Tears
In an article recently published in the journal Talanta, researchers demonstrated a new approach to enable the specific detection of biomarkers in human tear by employing an aptamer-based graphene affinity nanosensor. The ability to detect [...]
How Nanotechnology Can Make a Splash in Aquaculture
Selenium (Se) is an essential element found in aquatic feeds that promotes the proper development, wellbeing, and fitness of marine animals. Selenium can be transformed into nanomaterials that are more easily accessible, absorbed, and consumed by [...]
Super-Resolution Imaging Method For Multiple Fluorescence Microscopy Applications
In an article recently published in the journal Nanotechnology, researchers employed a single particle imaging method for fluorescence excitation with moderate intensity to achieve spatial resolution. Here, the semiconductor nanocrystals were accessed, whose emission lifetimes [...]
Trials to begin on new SA COVID-19 vaccine
A new COVID-19 vaccine developed in South Australia and administered with a needle-free device is to begin human trials. Designed by University of Adelaide researchers the DNA vaccine also targets the Omicron variant of [...]
Towards Carbon Clean Manufacturing with Eco-Friendly Nano-Lubricants
Grinding is an essential manufacturing process, yet the heat due to friction associated with the process causes damage to the part being processed. Lubrication is used to reduce friction; however, traditional petroleum-based lubricants can [...]
Researchers develop hybrid sensor that could help diagnose cancer
A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment response assessment. Today, the device can identify gases and [...]
Scientists Develop ‘Nanomachines’ That Can Penetrate And Kill Cancer Cells
Researchers have made a scientific breakthrough with the development of ‘nanomachines’ that can kill cancerous cells. The research team headed by Dr Youngdo Jeong from the Center for Advanced Biomolecular Recognition at the Korea Institute of Science and Technology (KIST) has engineered [...]
Green Method to Make Nanoparticles and Ultrafine Powder
A novel freeze-dissolving approach has been devised that offers greater efficiency and sustainability compared to the classic freeze-drying process to make superfine powder or nanoparticles. In the research published in the journal ACS Sustainable Chemistry & Engineering, sphere-shaped [...]
Participants wanted for study on the regulation of what future AI-driven nanomedicines should look like
Would you like to help in some research on the regulation of what future AI-driven nanomedicines should look like? If so, researchers at the University of Bristol are looking for volunteers to discuss ethical [...]
Could gold nanoparticles help treat cancer?
Gold nanoparticles are minuscule particles made of gold. From drug and gene delivery to photothermal and photodynamic therapies to screening and diagnostic tests to radiation therapy, X-ray imaging and CT scans, these small particles [...]
Carbon Dots Target Nucleolus and Monitor in Real-Time
In an article recently published in the journal Applied Surface Science, the researchers synthesized green fluorescent carbon dots (G-CDs) from 3,5-diaminobenzoic acid and citric acid. The as-prepared G-CDs were used to target the nucleolus and [...]
Green Nanoformulation for Anti-Cancer and Antibacterial Functions
Doxorubicin (DOX) is a powerful anti-cancer medication, and efforts have been made to design nanostructures for delivering it to cancerous cells. The nanostructures increase the cytotoxic effects of DOX on cancerous cells, while reducing the negative effects [...]
New drug delivery system releases therapeutic cargo only when bacteria are present
A team of Brown University researchers has developed a new responsive material that is able to release encapsulated cargo only when pathogenic bacteria are present. The material could be used to make wound dressings [...]
Hairy Cell Leukemia Complicated by Severe COVID-19: A Case Study
Novel three-drug regimen used to manage life-threatening developments. In April 2021, a 42-year-old man reached out to Brian Hill, MD, PhD, for a second opinion after being diagnosed with hairy cell leukemia following a bone [...]
We’re now in the ‘age of pandemics’. Can we stop the next one?
When the virus hunters landed in the remote African village of Yambuku in 1976, the nuns warned them to stay back. The sisters had cordoned off the area where they were caring for people [...]
Leave A Comment